Owner: | ![]() |
Entity Statement | CORPORATION |
Address | (Magokdong, Bio Innovation Park) 172, Magokjungang-ro, Gangseo-gu Seoul 07789 KR |
Legal Entity Type | Corporation |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 5 |
U.S. Codes: | 052,051,005,018,006,044,046 |
Type Code | Type |
---|---|
GS0051 | Pharmaceutical preparations for the treatment of diseases of the endocrine system; pharmaceutical agents affecting metabolism; cardiovascular treatment preparations; cardiovascular pharmaceutical preparations; pharmaceutical preparations for the treatment of kidney disorders; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for the treatment of diseases of the metabolic system; pharmaceutical preparations for the treatment of cardiovascular disease; medicines for the treatment of cardiovascular and cerebrovascular diseases; pills for dizziness symptoms treatment; biological preparations for medical purposes; cardiovascular agents for medical purposes; drugs for medical purposes; synthetic peptides for pharmaceutical purposes; pharmaceuticals; medicines for human purposes; anemia treatment medicines that stimulate red blood cell production; medicines to stimulate red blood cell production; medicines for treatment of chronic kidney disease and anemia; biological preparations for treatment of anemia; biological preparations to stimulate red blood cell production for veterinary and medical purposes; synthetic peptides for pharmaceutical and anemia treatment purposes; synthetic peptides for pharmaceutical and kidney disease treatment purposes. |
Description | Date | Event Coding |
---|---|---|
SN ASSIGNED FOR SECT 66A APPL FROM IB | 2024-03-14 | 1 REPR M: |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2024-03-22 | 2 NWOS I:Incoming Correspondence |
APPLICATION FILING RECEIPT MAILED | 2024-04-24 | 3 MAFR O:Outgoing Correspondence |
ASSIGNED TO EXAMINER | 2024-07-23 | 4 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2024-07-23 | 5 CNRT R:Renewal |
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2024-07-24 | 6 RFCR E:E-Mail |
REFUSAL PROCESSED BY MPU | 2024-08-08 | 7 RFRR P: |
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2024-08-08 | 8 RFCS P: |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.